Herzog and Moore Mull Over the Role of Maintenance PARP Inhibition in Ovarian Cancer
Season 3, Episode 36, Sep 07, 2020, 06:40 PM
In our exclusive interview, Dr. Herzog and Dr. Moore reviewed the topline results of the 4 positive PARP inhibitor trials in the frontline maintenance setting and provided perspective on the potential applications of these data to clinical practice.